Article
FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors.
Pharmacogenomics - 1 Jan 2015
Montes Ariana, Perez-Pampin Eva, Joven Beatriz, Carreira Patricia, Fernández-Nebro Antonio, Del Carmen Ordóñez María, Navarro-Sarabia Federico, Moreira Virginia, Vasilopoulos Yiannis, Sarafidou Theologia, Caliz Rafael, Ferrer Miguel Angel, Cañete Juan D, de la Serna Arturo R, Magallares Berta, Narváez Javier, Gómez-Reino Juan J, Gonzalez Antonio
Abstract excerpt
OBJECTIVES: Reproducible association of a functional polymorphism in FCGR2A with response to a TNF inhibitor (TNFi) in patients with rheumatoid arthritis (RA) led us to explore other FcγR functional polymorphisms. METHODS: Functional polymorphisms FCGR3A F158V, FCGR2B I223T and promoter VNTR in FCGRT were analyzed in up to 429 patients with RA. Response to TNFi was recorded during standard care at 3, 6 and 12...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
